On Tuesday, Trupanion reached a noteworthy technical benchmark, with its Relative Strength (RS) Rating jumping into the 90-plus percentile with an upgrade to 92, an increase from 83 the day before.
IBD's proprietary rating tracks price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the best stocks typically have an RS Rating north of 80 at the beginning of a new price run.
How To Use Stock Charts To Stay Profitable And Protected
Trupanion is working on a consolidation with a 57.90 buy point. See if it can break out in volume at least 40% higher than normal.
Trupanion showed 0% EPS growth last quarter, while sales growth came in at 15%. Look for the next report on or around Feb. 19.
Trupanion holds the No. 2 rank among its peers in the Insurance-Accident & Healthcare industry group. Unum Group is the top-ranked stock within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
